Drug shortage
Ezetimibe Tablet · Actavis Pharma, Inc.
FDA drug shortage · To Be Discontinued · updated Jun 27, 2025
Key facts
| Generic name | Ezetimibe Tablet |
|---|---|
| Company | Actavis Pharma, Inc. |
| Presentation | Ezetimibe, Tablet, 10 mg (NDC 0591-3713-19) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 0591-3713-19 |
| First posted | Jun 27, 2025 |
| Last updated | Jun 27, 2025 |
| Discontinued | Jun 27, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: